Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy‐induced peripheral neuropathy
Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, et al.
European Journal of Pain (2022) Vol. 26, Iss. 9, pp. 1950-1966
Closed Access | Times Cited: 25

Showing 25 citing articles:

Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids
Mohammad‐Reza Ghovanloo, Sidharth Tyagi, Peng Zhao, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 4
Open Access | Times Cited: 2
The Potential of Cannabichromene (CBC) as a Therapeutic Agent
Diana E. Sepúlveda, Kent E. Vrana, Joshua J. Kellogg, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 206-213
Open Access | Times Cited: 9
Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy
W. G. Warren, Myles Osborn, Christopher Tsantoulas, et al.
Journal of Pain (2024) Vol. 25, Iss. 7, pp. 104470-104470
Closed Access | Times Cited: 8
Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain
Abigail M. Schwarz, Dea Kobeci, Jessica Mancuso, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 214-221
Open Access | Times Cited: 7
Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment
Marina Mattar, Florence Umutoni, Ahmed S. Hassan, et al.
Life (2024) Vol. 14, Iss. 8, pp. 991-991
Open Access | Times Cited: 7
The antinociceptive activity and mechanism of action of cannabigerol
Yuting Wen, Zefeng Wang, Rui Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114163-114163
Open Access | Times Cited: 15
Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain
Rahul Nachnani, Diana E. Sepúlveda, Jennifer L. Booth, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1442-1442
Open Access | Times Cited: 14
Animal models of cisplatin‐induced neuropathic pain
Ningxin Li, Mingzhu Li, Shengbo Jin, et al.
Animal Models and Experimental Medicine (2025)
Open Access
Systematic biotechnological production of isoprenoid analogs with bespoke carbon skeletons
Lina Wang, Mads Rosenfeldt, Aikaterini Koutsaviti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Entourage effects of non-psychotropic cannabinoids (npCBs) on visceral sensitivity in experimental colitis
Kristofer Svendsen, Amyaouch Bradaia, María A. Gandini, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 3, pp. 103389-103389
Closed Access
The Pharmacology of Cannabinoids in Chronic Pain
Alonso Cortez-Resendiz, Timothy J Leiter, S. Riela, et al.
Medical Cannabis and Cannabinoids (2025)
Open Access
Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy
Francisco T. Chacon, Wesley M. Raup‐Konsavage, Kent E. Vrana, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3142-3142
Open Access | Times Cited: 18
Combinations of Cannabidiol and Δ9-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
Diana E. Sepúlveda, Kent E. Vrana, Nicholas Graziane, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2548-2548
Open Access | Times Cited: 17
Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests
Wesley M. Raup‐Konsavage, Diana E. Sepúlveda, Jian Wang, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 83-83
Open Access | Times Cited: 9
Cannabidiol and Cannabigerol, Nonpsychotropic Cannabinoids, as Analgesics that Effectively Manage Bone Fracture Pain and Promote Healing in Mice
Deepak Kumar Khajuria, Vengadeshprabhu Karuppagounder, Irena Nowak, et al.
Journal of Bone and Mineral Research (2023) Vol. 38, Iss. 11, pp. 1560-1576
Open Access | Times Cited: 8
High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
Benjamin D. Anderson, Diana E. Sepúlveda, Rahul Nachnani, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 390, Iss. 3, pp. 331-341
Closed Access | Times Cited: 2
ART26.12, a novel fatty acid‐binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models
W. G. Warren, Mary Osborn, Ana David-Pereira, et al.
European Journal of Pain (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 2
Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential
Shijia Li, Weini Li, Naseeb Kaur Malhi, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5471-5471
Open Access | Times Cited: 2
Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain
Elise M. Weerts, Bryan W. Jenkins, Robbie Y Kuang, et al.
Pharmacology Biochemistry and Behavior (2024), pp. 173883-173883
Closed Access | Times Cited: 1
Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain
Wesley M. Raup‐Konsavage, Diana E. Sepúlveda, Daniel P. Morris, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1869-1869
Open Access | Times Cited: 6
Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023
Marc Lewis, Saeid Baroutian, Sara M. Hanning
Current Pain and Headache Reports (2023) Vol. 28, Iss. 3, pp. 109-118
Closed Access | Times Cited: 3
Non-Intoxicating Cannabinoids in Visceral Pain
Kristofer Svendsen, Keith A. Sharkey, Christophe Altier
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 1, pp. 3-11
Closed Access | Times Cited: 2
Medicinal Cannabis for Alzheimer's Disease
Genevieve Z. Steiner, Madilyn Coles, Kayla Jaye, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2023), pp. 1-47
Closed Access | Times Cited: 1
Uso medicinal da Cannabis sativa L. (Cannabaceae): aspectos biológicos e a legislação no Brasil
Emily Thalia Teixeira da Silva, Luiz Domingues de Almeida
Deleted Journal (2022) Vol. 17, Iss. 1, pp. 89-102
Open Access
Resultados preclínicos de cannabinoides y dolor (algunos)
Carlos Goicoechea, Marina Sanz González, Miguel Ángel Martínez‐García, et al.
Revista de la Sociedad Española del Dolor (2022)
Open Access
Page 1

Scroll to top